SeltaSquare Draws Attention at Silicon Valley's 'Plug and Play' with AI Pharmacovigilance Technology
페이지 정보
본문
Last June, at the 'Global Startup Showcase' session held on the third day of the Plug and Play event in Silicon Valley — the world's hub of innovative technology — SeltaSquare CEO Shin Min-kyung attracted significant attention as she introduced the company's AI-powered pharmacovigilance capabilities. Plug and Play is a premier platform where startups from around the world showcase their innovative ideas and technologies.
CEO Shin Min-kyung delivered a presentation on SeltaSquare's "AI/DX-Based Full-Lifecycle Safety Monitoring Platform Technology," proposing a dramatically improved approach compared to conventional pharmacovigilance systems.
The pharmacovigilance solution introduced at the event minimizes human error in the data processing workflow and enhances data accuracy. AI algorithms play a particularly important role in data cleansing and analysis, enabling decision-makers to reach more accurate and timely conclusions. In addition, standardization tasks tailored to complex regulatory environments are automated through AI, streamlining the regulatory compliance process and making it significantly more efficient.
As the importance of standardization and digital transformation in pharmaceutical safety management data is increasingly emphasized worldwide, SeltaSquare's platform is equipped with capabilities to handle multilingual data processing and multinational regulatory requirements that may arise throughout drug development and distribution — making it highly applicable in global markets.
CEO Shin Min-kyung reflected: "Through this presentation, we received high praise for the potential of AI-driven pharmacovigilance systems. It reaffirmed the possibilities of applying AI in the medical field. We will continue to research and develop our technology so that it can provide tangible benefits in the bio sector."
Meanwhile, SeltaSquare has begun its global expansion through a partnership agreement with Oracle Argus, a world-class Safety Database. This Plug and Play appearance is expected to mark the beginning of SeltaSquare's AI-based pharmacovigilance platform reaching audiences not just in Korea, but around the world.
Read the Original Article on AVING News: [Pangyo AI] SeltaSquare Draws Attention at Silicon Valley's 'Plug and Play' with AI Pharmacovigilance Technology
